Asset Management One Co. Ltd. Trims Stake in DaVita Inc. (NYSE:DVA)

Asset Management One Co. Ltd. lowered its stake in shares of DaVita Inc. (NYSE:DVA) by 1.3% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 19,381 shares of the company’s stock after selling 248 shares during the period. Asset Management One Co. Ltd.’s holdings in DaVita were worth $2,990,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. MML Investors Services LLC increased its position in shares of DaVita by 1.3% during the third quarter. MML Investors Services LLC now owns 5,300 shares of the company’s stock valued at $869,000 after buying an additional 68 shares during the period. Exchange Traded Concepts LLC increased its position in shares of DaVita by 8.3% during the fourth quarter. Exchange Traded Concepts LLC now owns 891 shares of the company’s stock valued at $133,000 after buying an additional 68 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its position in shares of DaVita by 1.5% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,759 shares of the company’s stock valued at $776,000 after buying an additional 70 shares during the period. Impact Partnership Wealth LLC increased its position in shares of DaVita by 3.7% during the fourth quarter. Impact Partnership Wealth LLC now owns 1,941 shares of the company’s stock valued at $290,000 after buying an additional 70 shares during the period. Finally, Contravisory Investment Management Inc. increased its position in shares of DaVita by 1.2% during the fourth quarter. Contravisory Investment Management Inc. now owns 6,082 shares of the company’s stock valued at $910,000 after buying an additional 73 shares during the period. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Barclays upped their price objective on shares of DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $162.80.

DaVita Price Performance

Shares of DVA opened at $154.84 on Thursday. The stock has a market cap of $12.39 billion, a PE ratio of 14.42, a price-to-earnings-growth ratio of 0.79 and a beta of 0.94. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. DaVita Inc. has a fifty-two week low of $119.42 and a fifty-two week high of $179.60. The firm’s 50-day simple moving average is $161.40 and its two-hundred day simple moving average is $157.89.

DaVita (NYSE:DVA) last issued its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Analysts anticipate that DaVita Inc. will post 10.93 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.